Influenza virus vaccine should be given to target-group members who are at the highest risk

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1467, 2004-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

WHO recommendations to establish a stockpile of vaccine against H5N1 influenza virus have received support from vaccine manufacturers

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 528, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

The influenza matrix protein 2 as a vaccine target

By Saelens Xavier  

Future Virology, Vol. 3, Iss. 2, 2008-03 ,pp. : 167-178

Future Medicine

Access to resources Recommend Favorite

Influenza virus vaccine: Systemic anaphylaxis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1204, 2008-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Liposomal influenza virus vaccine immunogenic in CF

By  

Inpharma, Vol. 1, Iss. 1242, 2000-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Influenza virus vaccine fails to prevent asthma exacerbations

By  

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite